Phase 1 Lymphoid Malignancies Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Lymphoid Malignancies
AVM Biotechnology Inc144 enrolled11 locationsNCT04329728
Recruiting
Phase 1
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
AMLMyelodysplastic SyndromesCML+3 more
University of Alabama at Birmingham50 enrolled1 locationNCT06047886
Recruiting
Phase 1
A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies
Relapsed or Refractory Lymphoid Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.22 enrolled1 locationNCT06718634
Recruiting
Phase 1
A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)
Select Relapsed/Refractory Lymphoid Malignancies
Aurigene Discovery Technologies Limited42 enrolled5 locationsNCT06761586